Literature DB >> 6088632

Enhanced release of oxygen metabolites by monocyte-derived macrophages exposed to proteolytic enzymes: activity of neutrophil elastase and cathepsin G.

C P Speer, M J Pabst, H B Hedegaard, R F Rest, R B Johnston.   

Abstract

Macrophages at sites of inflammation are exposed to proteolytic enzymes derived from neutrophils, platelets, clotting factors, complement, and damaged tissues. To investigate the possible effect of proteases on the plasma membrane-mediated oxidative metabolic response of macrophages in inflammatory sites, cultured human monocyte-derived macrophages were treated in vitro with proteolytic enzymes and were then assayed for their ability to release superoxide anion (O2-) and hydrogen peroxide (H2O2) in response to stimuli. Macrophages pretreated for 1 to 20 min with trypsin, chymotrypsin, pronase, or papain, 0.1 to 200 micrograms/ml, released up to 3.5-times more O2- and H2O2 than did control (untreated) cells. This enhanced production of oxygen metabolites was observed by using either phorbol myristate acetate or opsonized zymosan as the stimulus. Macrophages were also "primed" for enhanced O2- release (2.3-fold) by pretreatment with a subfraction of granules extracted from human neutrophils. This subfraction contained primarily elastase and cathepsin G. Similar enhancement was observed with 60 ng/ml or purified human neutrophil cathepsin G (2.2-fold) and with 20 micrograms/ml of purified neutrophil elastase (3.3-fold). Priming by these neutrophil proteases could be blocked by specific inhibitors of their proteolytic activity. These results suggest that macrophages involved in an inflammatory response might be rapidly primed by proteases released from degranulating neutrophils. Primed macrophages could mount a more effective oxidative metabolic response to microorganisms or tumor cells, but might also cause greater tissue damage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088632

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Requirement for cell-bound proteases in the mechanism of human neutrophil activation with various stimuli.

Authors:  R J Smith; S C Speziale; L M Sam; J M Justen; B J Bowman
Journal:  Inflammation       Date:  1986-09       Impact factor: 4.092

Review 2.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Influence of neutrophil cationic proteins on generation of superoxide by human polymorphonuclear cells during phagocytosis.

Authors:  M Alam; N S Ranadive; W Pruzanski
Journal:  Inflammation       Date:  1987-06       Impact factor: 4.092

4.  Monoclonal antibody characterization of a chymotrypsin-like molecule on neutrophil membrane associated with cellular activation.

Authors:  C H King; C H Goralnik; P J Kleinhenz; J A Marino; J R Sedor; A A Mahmoud
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

5.  The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection.

Authors:  T Bruns; J Peter; S Hagel; A Herrmann; A Stallmach
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

6.  Complement and experimental respiratory failure.

Authors:  P A Ward; K J Johnson; G O Till
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

Review 7.  The role of free oxygen radicals in the expulsion of primary infections of Nippostrongylus brasiliensis.

Authors:  N C Smith
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

8.  Neutrophils reduce the parasite burden in Leishmania (Leishmania) amazonensis-infected macrophages.

Authors:  Erico Vinícius de Souza Carmo; Simone Katz; Clara Lúcia Barbiéri
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

9.  Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions.

Authors:  P J Ossanna; S T Test; N R Matheson; S Regiani; S J Weiss
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

10.  Serine protease inhibitors block priming of monocytes for enhanced release of superoxide.

Authors:  P Megyeri; K M Pabst; M J Pabst
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.